{"title":"葡萄膜黑色素瘤:质子束照射。","authors":"Evangelos S Gragoudas, Anne Marie Lane","doi":"10.1016/j.ohc.2004.08.002","DOIUrl":null,"url":null,"abstract":"<p><p>Over the past two decades, radiotherapy has replaced enucleation as the standard treatment for uveal melanoma. Although this method does not alter survival, preservation of the globe and, in some instances, visual function, is achieved. This article presents the authors' and other investigators' experience with proton therapy.</p>","PeriodicalId":82231,"journal":{"name":"Ophthalmology clinics of North America","volume":"18 1","pages":"111-8, ix"},"PeriodicalIF":0.0000,"publicationDate":"2005-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ohc.2004.08.002","citationCount":"82","resultStr":"{\"title\":\"Uveal melanoma: proton beam irradiation.\",\"authors\":\"Evangelos S Gragoudas, Anne Marie Lane\",\"doi\":\"10.1016/j.ohc.2004.08.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Over the past two decades, radiotherapy has replaced enucleation as the standard treatment for uveal melanoma. Although this method does not alter survival, preservation of the globe and, in some instances, visual function, is achieved. This article presents the authors' and other investigators' experience with proton therapy.</p>\",\"PeriodicalId\":82231,\"journal\":{\"name\":\"Ophthalmology clinics of North America\",\"volume\":\"18 1\",\"pages\":\"111-8, ix\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ohc.2004.08.002\",\"citationCount\":\"82\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmology clinics of North America\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ohc.2004.08.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology clinics of North America","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ohc.2004.08.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Over the past two decades, radiotherapy has replaced enucleation as the standard treatment for uveal melanoma. Although this method does not alter survival, preservation of the globe and, in some instances, visual function, is achieved. This article presents the authors' and other investigators' experience with proton therapy.